2020 Cardiac Arrest Pulmonary 
Dr. Smith's ECG Blog
NOVEMBER 12, 2020
and the patient was converted to veno-venous (V-V) ECMO due to persistent pulmonary insufficiency. Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. Guo T, Fan Y, Chen M, et al.
Dr. Smith's ECG Blog
JANUARY 8, 2024
Smith interpretation: This is highly likely to be due to extreme right heart strain and is nearly diagnostic of pulmonary embolism. What is the clear diagnosis and reason for arrest? It is of course pulmonary embolism. No d-dimer or CT pulmonary angiogram was done when they discovered that she had normal coronary arteries.
Ken Grauer, MD
JULY 9, 2023
Blood was drawn , and the patient was promptly placed in a room to be seen — but on entering, the ED physician found her unresponsive in cardiac arrest. Do you see any indication on this ECG of WHY this patient was about to arrest? Is there any indication on this ECG of WHY this patient shortly after had a cardiac arrest?
Dr. Smith's ECG Blog
OCTOBER 23, 2023
Edited by Bracey, Meyers, Grauer, and Smith A 50-something-year-old female with a history of an unknown personality disorder and alcohol use disorder arrived via EMS following cardiac arrest with return of spontaneous circulation. Cardiac Motion Alternans — is the result of cardiac movement rather than electrical alternation.
Ken Grauer, MD
JUNE 6, 2023
I've previously discussed the interesting correlation of a qR pattern in lead V1 in patients with RVH — as strongly suggesting associated pulmonary hypertension ( See ECG Blog #234 and Blog #248 ). Unfortunately — the patient abruptly developed hypoxemia, followed by cardiac arrest with PEA. He could not be resuscitated.
Dr. Smith's ECG Blog
OCTOBER 17, 2024
Smith comment: before reading anything else, this case screamed pulmonary embolism to me. I would do bedside ultrasound to look at the RV, look for B lines as a cause of hypoxia (which would support OMI, and argue against PE), and if any doubt persists, a rapid CT pulmonary angiogram.
Cardiometabolic Health Congress
JULY 17, 2024
Notes: Approved after initial rejection two years prior based on safety data from Japan, where the drug had been used since 2020 It can only be used in kidney disease patients on dialysis for at least 3 months. Clinical Trial Results: Aprocitentan reduced and maintained lower BP levels over time, both in SiSBP and SiDBP.
Expert insights. Personalized for you.
52 
Let's personalize your content